Gene modifiers of cystic fibrosis lung disease: A systematic review.

Shivanthan ShanthikumarMelanie N NeelandRichard SafferySarath Ranganathan
Published in: Pediatric pulmonology (2019)
A large body of evidence regarding non-CFTR gene modifiers of lung disease severity has been generated, examining a wide array of genes. Limitations to existing studies include heterogeneity in outcome measures used, limited replication, and relative lack of clinical impact. Future work examining non-CFTR gene modifiers will have to overcome these limitations if gene modifiers are to have a meaningful role in the care of patients with CF.